These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 29852774)

  • 41. Sporadic multiple meningiomas harbor distinct driver mutations.
    Juratli TA; Prilop I; Saalfeld FC; Herold S; Meinhardt M; Wenzel C; Zeugner S; Aust DE; Barker FG; Cahill DP; Brastianos PK; Santagata S; Schackert G; Pinzer T
    Acta Neuropathol Commun; 2021 Jan; 9(1):8. PubMed ID: 33407897
    [No Abstract]   [Full Text] [Related]  

  • 42. KLF4
    von Spreckelsen N; Waldt N; Poetschke R; Kesseler C; Dohmen H; Jiao HK; Nemeth A; Schob S; Scherlach C; Sandalcioglu IE; Deckert M; Angenstein F; Krischek B; Stavrinou P; Timmer M; Remke M; Kirches E; Goldbrunner R; Chiocca EA; Huettelmaier S; Acker T; Mawrin C
    Acta Neuropathol Commun; 2020 Apr; 8(1):41. PubMed ID: 32245394
    [TBL] [Abstract][Full Text] [Related]  

  • 43. WHO grade III meningioma: De novo tumors show improved progression free survival as compared to secondary progressive tumors.
    Ruzevick J; Gibson A; Tatman P; Emerson S; Ferreira M
    J Clin Neurosci; 2021 Sep; 91():105-109. PubMed ID: 34373013
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Meningiomas induced by low-dose radiation carry structural variants of NF2 and a distinct mutational signature.
    Sahm F; Toprak UH; Hübschmann D; Kleinheinz K; Buchhalter I; Sill M; Stichel D; Schick M; Bewerunge-Hudler M; Schrimpf D; Zadeh G; Aldape K; Herold-Mende C; Beck K; Staszewski O; Prinz M; Harosh CB; Eils R; Sturm D; Jones DTW; Pfister SM; Paulus W; Ram Z; Schlesner M; Grossman R; von Deimling A
    Acta Neuropathol; 2017 Jul; 134(1):155-158. PubMed ID: 28474103
    [No Abstract]   [Full Text] [Related]  

  • 45. Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomas.
    Agnihotri S; Suppiah S; Tonge PD; Jalali S; Danesh A; Bruce JP; Mamatjan Y; Klironomos G; Gonen L; Au K; Mansouri S; Karimi S; Sahm F; von Deimling A; Taylor MD; Laperriere NJ; Pugh TJ; Aldape KD; Zadeh G
    Nat Commun; 2017 Aug; 8(1):186. PubMed ID: 28775249
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Current Status of Genetic/Molecular Abnormality Analysis and Prognosis Prediction of Meningioma].
    Okano A
    No Shinkei Geka; 2024 Jul; 52(4):718-724. PubMed ID: 39034510
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epigenetic and genomic profiling of chordoid meningioma: implications for clinical management.
    Daoud EV; Zhu K; Mickey B; Mohamed H; Wen M; Delorenzo M; Tran I; Serrano J; Hatanpaa KJ; Raisanen JM; Snuderl M; Cai C
    Acta Neuropathol Commun; 2022 Apr; 10(1):56. PubMed ID: 35440040
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Whole exome sequencing in a case of sporadic multiple meningioma reveals shared NF2, FAM109B, and TPRXL mutations, together with unique SMARCB1 alterations in a subset of tumor nodules.
    Torres-Martín M; Kusak ME; Isla A; Burbano RR; Pinto GR; Melendez B; Castresana JS; Rey JA
    Cancer Genet; 2015 Jun; 208(6):327-32. PubMed ID: 25981829
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical Characteristics and Magnetic Resonance Imaging-Based Prediction of the KLF4
    von Spreckelsen N; Waldt N; Timmer M; Goertz L; Reinecke D; Laukamp K; Pennig L; Grau S; Deckert M; Kirches E; Stavrinou P; Mawrin C; Goldbrunner R
    World Neurosurg; 2021 Oct; 154():e665-e670. PubMed ID: 34343686
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biology and clinical management challenges in meningioma.
    Mawrin C; Chung C; Preusser M
    Am Soc Clin Oncol Educ Book; 2015; ():e106-15. PubMed ID: 25993161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evolving concepts in meningioma management in the era of genomics.
    Hsieh AL; Bi WL; Ramesh V; Brastianos PK; Plotkin SR
    Cancer; 2024 Aug; 130(15):2586-2600. PubMed ID: 38753473
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinicopathological and molecular characteristics of pediatric meningiomas.
    Battu S; Kumar A; Pathak P; Purkait S; Dhawan L; Sharma MC; Suri A; Singh M; Sarkar C; Suri V
    Neuropathology; 2018 Feb; 38(1):22-33. PubMed ID: 28901666
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A five year-old child with clear cell petro-clival meningioma: case report with clinical and histopathological long-term follow-up.
    Juratli TA; Geiger KD; Weigel P; von der Hagen M; Daubner D; Pinzer T; Hahn G; Schackert G; Kirsch M
    Childs Nerv Syst; 2015 Nov; 31(11):2193-8. PubMed ID: 26077595
    [TBL] [Abstract][Full Text] [Related]  

  • 54. POLR2A Mutation is a Poor Prognostic Marker of Cerebellopontine Angle Meningioma.
    Okano A; Miyawaki S; Teranishi Y; Hongo H; Dofuku S; Ohara K; Sakai Y; Shin M; Nakatomi H; Saito N
    Neurosurgery; 2024 Aug; 95(2):275-283. PubMed ID: 38380947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Landscape of genetic variants in sporadic meningiomas captured with clinical genomics.
    Leclair NK; Shen E; Wu Q; Wolansky L; Becker K; Li L; Bulsara KR
    Acta Neurochir (Wien); 2022 Sep; 164(9):2491-2503. PubMed ID: 35881312
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical and genomic differences in supratentorial versus infratentorial NF2 mutant meningiomas.
    Tabor JK; O'Brien J; Vasandani S; Vetsa S; Lei H; Jalal MI; Marianayagam NJ; Jin L; Millares Chavez M; Haynes J; Dincer A; Yalcin K; Aguilera SM; Omay SB; Mishra-Gorur K; McGuone D; Morales-Valero SF; Fulbright RK; Gunel M; Erson-Omay EZ; Moliterno J
    J Neurosurg; 2023 Dec; 139(6):1648-1656. PubMed ID: 37243548
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Associations of meningioma molecular subgroup and tumor recurrence.
    Youngblood MW; Miyagishima DF; Jin L; Gupte T; Li C; Duran D; Montejo JD; Zhao A; Sheth A; Tyrtova E; Özduman K; Iacoangeli F; Peyre M; Boetto J; Pease M; Avşar T; Huttner A; Bilguvar K; Kilic T; Pamir MN; Amankulor N; Kalamarides M; Erson-Omay EZ; Günel M; Moliterno J
    Neuro Oncol; 2021 May; 23(5):783-794. PubMed ID: 33068421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genomic analysis of non-neurofibromatosis type 2 meningiomas.
    Parry PV; Engh JA
    Neurosurgery; 2013 Jun; 72(6):N18-9. PubMed ID: 23685513
    [No Abstract]   [Full Text] [Related]  

  • 59. High resolution genomic profiling and classical cytogenetics in a group of benign and atypical meningiomas.
    Holland H; Mocker K; Ahnert P; Kirsten H; Hantmann H; Koschny R; Bauer M; Schober R; Scholz M; Meixensberger J; Krupp W
    Cancer Genet; 2011 Oct; 204(10):541-9. PubMed ID: 22137484
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role and regulatory mechanism of IL-1β on the methylation of the NF2 gene in benign meningiomas and leptomeninges.
    Wang B; Cui Z; Zhong Z; Sun Y; Yang GY; Sun Q; Bian L
    Mol Carcinog; 2016 Dec; 55(12):2268-2277. PubMed ID: 26840621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.